Amgen’s quarterly profit slid 1% but its revenue jumped 22%. Horizon Therapeutics, which Amgen bought last year for around $28 billion, contributed $914 million in sales. (MM+M)
Novartis announced it will pay $1 billion upfront to acquire radiopharmaceutical startup Mariana Oncology. The move comes eight months after Mariana announced a $175 million Series B funding round. (Endpoints News)
Peloton announced CEO Barry McCarthy will be stepping down and the company will lay off 15% of its staff as it aims to refinance its debt. Karen Boone, the company’s chairperson, and director Chris Bruzzo will serve as interim co-CEOs while Peloton seeks a permanent replacement. (CNBC)
Testing of pasteurized commercially purchased milk and other dairy products found no evidence of live H5N1 bird flu virus, Food and Drug Administration officials announced at a press briefing. The results confirmed findings of earlier testing of a more limited number of samples and add weight to the FDA’s conclusion that pasteurized milk products are safe for consumption despite a widespread outbreak of cows infected with H5N1. (STAT News)
A piece in Health Affairs argued that the time is now for federal reform of direct-to-consumer advertising of prescription drugs. “Specifically, continued resource deprivation and bureaucratic burdens hamstring the FDA from providing effective oversight of direct-to-consumer advertisements,” the authors wrote. (Health Affairs)
Click here to view yesterday’s Five things for pharma marketers to know.
